TCTC Holdings’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.1K | Hold |
1,668
| – | – | ﹤0.01% | 315 |
|
|
2025
Q1 | $64.6K | Sell |
1,668
-510
| -23% | -$19.8K | ﹤0.01% | 301 |
|
|
2024
Q4 | $73.7K | Buy |
2,178
+510
| +31% | +$17.2K | ﹤0.01% | 285 |
|
|
2024
Q3 | $68.2K | Hold |
1,668
| – | – | ﹤0.01% | 283 |
|
|
2024
Q2 | $64.2K | Hold |
1,668
| – | – | ﹤0.01% | 289 |
|
|
2024
Q1 | $71.5K | Hold |
1,668
| – | – | ﹤0.01% | 270 |
|
|
2023
Q4 | $61.8K | Buy |
1,668
+1,108
| +198% | +$41.1K | ﹤0.01% | 283 |
|
|
2023
Q3 | $20.3K | Hold |
560
| – | – | ﹤0.01% | 322 |
|
|
2023
Q2 | $20K | Sell |
560
-253
| -31% | -$9.02K | ﹤0.01% | 323 |
|
|
2023
Q1 | $28.9K | Hold |
813
| – | – | ﹤0.01% | 322 |
|
|
2022
Q4 | $28.6K | Hold |
813
| – | – | ﹤0.01% | 309 |
|
|
2022
Q3 | $24K | Sell |
813
-1
| -0.1% | -$30 | ﹤0.01% | 303 |
|
|
2022
Q2 | $44K | Hold |
814
| – | – | ﹤0.01% | 279 |
|
|
2022
Q1 | $44K | Hold |
814
| – | – | ﹤0.01% | 285 |
|
|
2021
Q4 | $45K | Hold |
814
| – | – | ﹤0.01% | 311 |
|
|
2021
Q3 | $39K | Hold |
814
| – | – | ﹤0.01% | 327 |
|
|
2021
Q2 | $40K | Hold |
814
| – | – | ﹤0.01% | 287 |
|
|
2021
Q1 | $36K | Sell |
814
-830
| -50% | -$36.7K | ﹤0.01% | 290 |
|
|
2020
Q4 | $76K | Hold |
1,644
| – | – | ﹤0.01% | 224 |
|
|
2020
Q3 | $77K | Hold |
1,644
| – | – | ﹤0.01% | 217 |
|
|
2020
Q2 | $84K | Buy |
+1,644
| New | +$84K | 0.01% | 209 |
|